🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

35,89 USD

Máx. histórico

41,81

54 días

Caída desde máximo

-14,16%

Rango 52 semanas

19,30 – 42,50

Variación hoy

-2,76%

Cierre anterior

36,91

Rango de hoy

35,81 – 37,29

Volumen hoy

5.699.508

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,49%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 13 horas
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/11/2026 36,95 37,29 35,81 35,89 -2,76% 4,01% 5.699.508
30/10/2026 37,11 37,94 36,78 36,91 -1,63% 3,12% 4.574.500
29/10/2026 37,44 37,97 37,29 37,52 +1,10% 1,82% 3.728.800
28/10/2026 36,43 37,13 36,13 37,11 +1,56% 2,74% 5.773.200
27/10/2026 35,94 36,83 35,80 36,54 +1,36% 2,87% 6.567.900
26/10/2026 36,66 36,91 35,66 36,05 -1,21% 3,41% 9.868.500
23/10/2026 37,18 37,42 36,36 36,49 -2,56% 2,85% 8.225.400
22/10/2026 36,68 38,49 36,68 37,45 +1,77% 4,93% 13.451.200
21/10/2026 38,15 38,49 35,99 36,80 +5,38% 6,55% 16.839.600
20/10/2026 35,00 35,52 34,38 34,92 +0,63% 3,24% 3.670.500
19/10/2026 33,78 35,14 33,60 34,70 +3,49% 4,56% 6.334.300
16/10/2026 34,12 34,12 33,23 33,53 -1,50% 2,61% 4.923.400
15/10/2026 33,82 34,36 33,70 34,04 +1,25% 1,94% 4.565.900
14/10/2026 33,14 34,09 33,00 33,62 +0,81% 3,29% 4.293.700
13/10/2026 34,44 34,92 33,26 33,35 -3,58% 4,81% 6.322.200
12/10/2026 34,92 35,41 34,55 34,59 -2,40% 2,46% 4.732.100
09/10/2026 34,24 35,59 34,15 35,44 +3,60% 4,21% 5.533.200
08/10/2026 34,28 34,56 33,32 34,21 -1,55% 3,62% 6.403.900
07/10/2026 35,22 35,49 34,63 34,75 -2,20% 2,43% 5.738.800
06/10/2026 35,86 36,34 34,75 35,53 -0,70% 4,43% 5.737.700
05/10/2026 35,98 36,33 35,25 35,78 +0,17% 3,00% 6.200.500
02/10/2026 35,61 36,00 35,19 35,72 +0,62% 2,27% 4.365.800
01/10/2026 36,35 36,79 35,44 35,50 -2,93% 3,73% 3.272.000
30/09/2026 36,77 36,96 36,23 36,57 +0,19% 1,97% 5.282.400
29/09/2026 37,03 37,35 35,75 36,50 -1,30% 4,31% 6.587.600
28/09/2026 35,65 37,25 35,28 36,98 +3,30% 5,51% 6.970.800
25/09/2026 35,98 36,19 35,52 35,80 -0,91% 1,88% 6.764.400
24/09/2026 36,64 36,75 35,91 36,13 -1,87% 2,31% 5.659.500
23/09/2026 38,00 38,47 36,78 36,82 -3,66% 4,45% 9.272.900
22/09/2026 38,73 39,17 38,11 38,22 -1,97% 2,74% 6.752.500